nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—DHFR—Methotrexate—multiple sclerosis	0.265	0.313	CbGbCtD
Proguanil—CYP2E1—Fingolimod—multiple sclerosis	0.143	0.169	CbGbCtD
Proguanil—CYP2D6—Fingolimod—multiple sclerosis	0.0683	0.0806	CbGbCtD
Proguanil—CYP2E1—Mitoxantrone—multiple sclerosis	0.0674	0.0795	CbGbCtD
Proguanil—CYP3A4—Fingolimod—multiple sclerosis	0.0434	0.0512	CbGbCtD
Proguanil—CYP2C19—Prednisone—multiple sclerosis	0.0351	0.0414	CbGbCtD
Proguanil—CYP2E1—Dexamethasone—multiple sclerosis	0.0349	0.0412	CbGbCtD
Proguanil—CYP3A4—Methylprednisolone—multiple sclerosis	0.028	0.033	CbGbCtD
Proguanil—CYP2C19—Dexamethasone—multiple sclerosis	0.0219	0.0258	CbGbCtD
Proguanil—CYP3A4—Triamcinolone—multiple sclerosis	0.0212	0.025	CbGbCtD
Proguanil—CYP3A4—Mitoxantrone—multiple sclerosis	0.0204	0.0241	CbGbCtD
Proguanil—CYP2C9—Dexamethasone—multiple sclerosis	0.0182	0.0215	CbGbCtD
Proguanil—CYP3A4—Betamethasone—multiple sclerosis	0.0182	0.0215	CbGbCtD
Proguanil—CYP3A4—Prednisolone—multiple sclerosis	0.018	0.0212	CbGbCtD
Proguanil—CYP3A4—Prednisone—multiple sclerosis	0.017	0.02	CbGbCtD
Proguanil—CYP2D6—Dexamethasone—multiple sclerosis	0.0166	0.0196	CbGbCtD
Proguanil—Elevated liver enzyme levels—Mitoxantrone—multiple sclerosis	0.0144	0.131	CcSEcCtD
Proguanil—CYP3A4—Dexamethasone—multiple sclerosis	0.0106	0.0125	CbGbCtD
Proguanil—DHFR—Nucleotide Metabolism—SRM—multiple sclerosis	0.00517	0.123	CbGpPWpGaD
Proguanil—Hepatic enzyme increased—Fingolimod—multiple sclerosis	0.00472	0.0428	CcSEcCtD
Proguanil—DHFR—Nucleotide Metabolism—RRM1—multiple sclerosis	0.00276	0.0658	CbGpPWpGaD
Proguanil—Mediastinal disorder—Fingolimod—multiple sclerosis	0.00202	0.0183	CcSEcCtD
Proguanil—Mental disorder—Fingolimod—multiple sclerosis	0.00196	0.0178	CcSEcCtD
Proguanil—DHFR—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00177	0.0423	CbGpPWpGaD
Proguanil—Hepatic enzyme increased—Mitoxantrone—multiple sclerosis	0.00176	0.0159	CcSEcCtD
Proguanil—Cough—Fingolimod—multiple sclerosis	0.0017	0.0154	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00165	0.015	CcSEcCtD
Proguanil—Nervous system disorder—Fingolimod—multiple sclerosis	0.00156	0.0142	CcSEcCtD
Proguanil—Skin disorder—Fingolimod—multiple sclerosis	0.00155	0.014	CcSEcCtD
Proguanil—Pancytopenia—Cladribine—multiple sclerosis	0.00151	0.0137	CcSEcCtD
Proguanil—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00138	0.0125	CcSEcCtD
Proguanil—Hepatobiliary disease—Cladribine—multiple sclerosis	0.00134	0.0121	CcSEcCtD
Proguanil—Pancytopenia—Azathioprine—multiple sclerosis	0.00123	0.0111	CcSEcCtD
Proguanil—Immune system disorder—Cladribine—multiple sclerosis	0.00115	0.0104	CcSEcCtD
Proguanil—Mediastinal disorder—Cladribine—multiple sclerosis	0.00115	0.0104	CcSEcCtD
Proguanil—Mental disorder—Cladribine—multiple sclerosis	0.00111	0.0101	CcSEcCtD
Proguanil—Erythema—Cladribine—multiple sclerosis	0.00111	0.01	CcSEcCtD
Proguanil—Malnutrition—Cladribine—multiple sclerosis	0.00111	0.01	CcSEcCtD
Proguanil—Diarrhoea—Fingolimod—multiple sclerosis	0.00109	0.00987	CcSEcCtD
Proguanil—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.00109	0.00986	CcSEcCtD
Proguanil—Headache—Fingolimod—multiple sclerosis	0.000998	0.00904	CcSEcCtD
Proguanil—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000991	0.00898	CcSEcCtD
Proguanil—Cough—Cladribine—multiple sclerosis	0.000965	0.00875	CcSEcCtD
Proguanil—DHFR—E2F transcription factor network—RRM1—multiple sclerosis	0.00094	0.0224	CbGpPWpGaD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000935	0.00848	CcSEcCtD
Proguanil—Immune system disorder—Azathioprine—multiple sclerosis	0.000933	0.00846	CcSEcCtD
Proguanil—Mediastinal disorder—Azathioprine—multiple sclerosis	0.000931	0.00844	CcSEcCtD
Proguanil—Stomatitis—Mitoxantrone—multiple sclerosis	0.000907	0.00822	CcSEcCtD
Proguanil—Nervous system disorder—Cladribine—multiple sclerosis	0.000885	0.00802	CcSEcCtD
Proguanil—Skin disorder—Cladribine—multiple sclerosis	0.000877	0.00795	CcSEcCtD
Proguanil—Hepatic enzyme increased—Methotrexate—multiple sclerosis	0.000876	0.00794	CcSEcCtD
Proguanil—Anorexia—Cladribine—multiple sclerosis	0.000861	0.0078	CcSEcCtD
Proguanil—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000817	0.0195	CbGpPWpGaD
Proguanil—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000817	0.0195	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000817	0.0195	CbGpPWpGaD
Proguanil—Decreased appetite—Cladribine—multiple sclerosis	0.000785	0.00711	CcSEcCtD
Proguanil—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000779	0.00706	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000761	0.00689	CcSEcCtD
Proguanil—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000738	0.00669	CcSEcCtD
Proguanil—Erythema—Mitoxantrone—multiple sclerosis	0.000727	0.00659	CcSEcCtD
Proguanil—Abdominal pain—Cladribine—multiple sclerosis	0.000714	0.00647	CcSEcCtD
Proguanil—Body temperature increased—Cladribine—multiple sclerosis	0.000714	0.00647	CcSEcCtD
Proguanil—Skin disorder—Azathioprine—multiple sclerosis	0.000713	0.00646	CcSEcCtD
Proguanil—Cough—Mitoxantrone—multiple sclerosis	0.000635	0.00575	CcSEcCtD
Proguanil—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000634	0.00574	CcSEcCtD
Proguanil—Hallucination—Methylprednisolone—multiple sclerosis	0.000626	0.00567	CcSEcCtD
Proguanil—Diarrhoea—Cladribine—multiple sclerosis	0.000618	0.0056	CcSEcCtD
Proguanil—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.0006	0.00544	CcSEcCtD
Proguanil—Erythema—Prednisolone—multiple sclerosis	0.000597	0.00541	CcSEcCtD
Proguanil—Abdominal pain—Azathioprine—multiple sclerosis	0.00058	0.00526	CcSEcCtD
Proguanil—Body temperature increased—Azathioprine—multiple sclerosis	0.00058	0.00526	CcSEcCtD
Proguanil—Skin disorder—Mitoxantrone—multiple sclerosis	0.000576	0.00522	CcSEcCtD
Proguanil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000575	0.0137	CbGpPWpGaD
Proguanil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000575	0.0137	CbGpPWpGaD
Proguanil—Vomiting—Cladribine—multiple sclerosis	0.000574	0.0052	CcSEcCtD
Proguanil—Rash—Cladribine—multiple sclerosis	0.000569	0.00516	CcSEcCtD
Proguanil—Hallucination—Betamethasone—multiple sclerosis	0.000569	0.00516	CcSEcCtD
Proguanil—Hallucination—Dexamethasone—multiple sclerosis	0.000569	0.00516	CcSEcCtD
Proguanil—Dermatitis—Cladribine—multiple sclerosis	0.000569	0.00515	CcSEcCtD
Proguanil—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000568	0.00515	CcSEcCtD
Proguanil—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000567	0.00514	CcSEcCtD
Proguanil—Anorexia—Mitoxantrone—multiple sclerosis	0.000566	0.00513	CcSEcCtD
Proguanil—Headache—Cladribine—multiple sclerosis	0.000566	0.00513	CcSEcCtD
Proguanil—Mental disorder—Methylprednisolone—multiple sclerosis	0.000551	0.00499	CcSEcCtD
Proguanil—Erythema—Triamcinolone—multiple sclerosis	0.000549	0.00497	CcSEcCtD
Proguanil—Erythema—Methylprednisolone—multiple sclerosis	0.000547	0.00496	CcSEcCtD
Proguanil—Malnutrition—Methylprednisolone—multiple sclerosis	0.000547	0.00496	CcSEcCtD
Proguanil—Nausea—Cladribine—multiple sclerosis	0.000536	0.00486	CcSEcCtD
Proguanil—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000519	0.0124	CbGpPWpGaD
Proguanil—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000519	0.0124	CbGpPWpGaD
Proguanil—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000516	0.00467	CcSEcCtD
Proguanil—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000512	0.0122	CbGpPWpGaD
Proguanil—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000512	0.0122	CbGpPWpGaD
Proguanil—Diarrhoea—Azathioprine—multiple sclerosis	0.000502	0.00455	CcSEcCtD
Proguanil—Erythema—Dexamethasone—multiple sclerosis	0.000498	0.00451	CcSEcCtD
Proguanil—Erythema—Betamethasone—multiple sclerosis	0.000498	0.00451	CcSEcCtD
Proguanil—Hallucination—Prednisone—multiple sclerosis	0.000495	0.00449	CcSEcCtD
Proguanil—Pancytopenia—Methotrexate—multiple sclerosis	0.000494	0.00447	CcSEcCtD
Proguanil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000491	0.0117	CbGpPWpGaD
Proguanil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000491	0.0117	CbGpPWpGaD
Proguanil—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000485	0.0044	CcSEcCtD
Proguanil—Cough—Triamcinolone—multiple sclerosis	0.000479	0.00434	CcSEcCtD
Proguanil—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000469	0.00425	CcSEcCtD
Proguanil—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000469	0.00425	CcSEcCtD
Proguanil—Vomiting—Azathioprine—multiple sclerosis	0.000467	0.00423	CcSEcCtD
Proguanil—Rash—Azathioprine—multiple sclerosis	0.000463	0.00419	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000463	0.00419	CcSEcCtD
Proguanil—Dermatitis—Azathioprine—multiple sclerosis	0.000462	0.00419	CcSEcCtD
Proguanil—Headache—Azathioprine—multiple sclerosis	0.00046	0.00417	CcSEcCtD
Proguanil—Stomatitis—Methotrexate—multiple sclerosis	0.000452	0.00409	CcSEcCtD
Proguanil—Immune system disorder—Prednisone—multiple sclerosis	0.00045	0.00408	CcSEcCtD
Proguanil—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000438	0.00397	CcSEcCtD
Proguanil—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000438	0.00397	CcSEcCtD
Proguanil—Mental disorder—Prednisone—multiple sclerosis	0.000436	0.00395	CcSEcCtD
Proguanil—Nausea—Azathioprine—multiple sclerosis	0.000436	0.00395	CcSEcCtD
Proguanil—Skin disorder—Methylprednisolone—multiple sclerosis	0.000434	0.00393	CcSEcCtD
Proguanil—Malnutrition—Prednisone—multiple sclerosis	0.000434	0.00393	CcSEcCtD
Proguanil—Erythema—Prednisone—multiple sclerosis	0.000434	0.00393	CcSEcCtD
Proguanil—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00042	0.01	CbGpPWpGaD
Proguanil—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00042	0.01	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—IL4—multiple sclerosis	0.000416	0.00992	CbGpPWpGaD
Proguanil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000406	0.00368	CcSEcCtD
Proguanil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.0004	0.00954	CbGpPWpGaD
Proguanil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.0004	0.00954	CbGpPWpGaD
Proguanil—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000398	0.00361	CcSEcCtD
Proguanil—Nervous system disorder—Betamethasone—multiple sclerosis	0.000398	0.00361	CcSEcCtD
Proguanil—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000395	0.00942	CbGpPWpGaD
Proguanil—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000395	0.00942	CbGpPWpGaD
Proguanil—Anorexia—Dexamethasone—multiple sclerosis	0.000387	0.00351	CcSEcCtD
Proguanil—Anorexia—Betamethasone—multiple sclerosis	0.000387	0.00351	CcSEcCtD
Proguanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000379	0.00904	CbGpPWpGaD
Proguanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000379	0.00904	CbGpPWpGaD
Proguanil—Vomiting—Mitoxantrone—multiple sclerosis	0.000377	0.00342	CcSEcCtD
Proguanil—Immune system disorder—Methotrexate—multiple sclerosis	0.000376	0.00341	CcSEcCtD
Proguanil—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000375	0.0034	CcSEcCtD
Proguanil—Rash—Mitoxantrone—multiple sclerosis	0.000374	0.00339	CcSEcCtD
Proguanil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000374	0.00339	CcSEcCtD
Proguanil—Headache—Mitoxantrone—multiple sclerosis	0.000372	0.00337	CcSEcCtD
Proguanil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000368	0.00878	CbGpPWpGaD
Proguanil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000368	0.00878	CbGpPWpGaD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000367	0.00332	CcSEcCtD
Proguanil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000365	0.00331	CcSEcCtD
Proguanil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000365	0.0087	CbGpPWpGaD
Proguanil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000365	0.0087	CbGpPWpGaD
Proguanil—Mental disorder—Methotrexate—multiple sclerosis	0.000365	0.0033	CcSEcCtD
Proguanil—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000363	0.00866	CbGpPWpGaD
Proguanil—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000363	0.00866	CbGpPWpGaD
Proguanil—Erythema—Methotrexate—multiple sclerosis	0.000362	0.00328	CcSEcCtD
Proguanil—Malnutrition—Methotrexate—multiple sclerosis	0.000362	0.00328	CcSEcCtD
Proguanil—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00036	0.00859	CbGpPWpGaD
Proguanil—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00036	0.00859	CbGpPWpGaD
Proguanil—Body temperature increased—Triamcinolone—multiple sclerosis	0.000354	0.00321	CcSEcCtD
Proguanil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000353	0.0032	CcSEcCtD
Proguanil—Decreased appetite—Betamethasone—multiple sclerosis	0.000353	0.0032	CcSEcCtD
Proguanil—Decreased appetite—Dexamethasone—multiple sclerosis	0.000353	0.0032	CcSEcCtD
Proguanil—Nausea—Mitoxantrone—multiple sclerosis	0.000353	0.00319	CcSEcCtD
Proguanil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000351	0.00318	CcSEcCtD
Proguanil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000351	0.00318	CcSEcCtD
Proguanil—Nervous system disorder—Prednisone—multiple sclerosis	0.000347	0.00314	CcSEcCtD
Proguanil—Skin disorder—Prednisone—multiple sclerosis	0.000344	0.00311	CcSEcCtD
Proguanil—Anorexia—Prednisone—multiple sclerosis	0.000337	0.00306	CcSEcCtD
Proguanil—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000336	0.008	CbGpPWpGaD
Proguanil—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000332	0.00301	CcSEcCtD
Proguanil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000332	0.00301	CcSEcCtD
Proguanil—DHFR—Folate Metabolism—ICAM1—multiple sclerosis	0.000331	0.00788	CbGpPWpGaD
Proguanil—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000324	0.00774	CbGpPWpGaD
Proguanil—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000324	0.00774	CbGpPWpGaD
Proguanil—Body temperature increased—Dexamethasone—multiple sclerosis	0.000321	0.00291	CcSEcCtD
Proguanil—Body temperature increased—Betamethasone—multiple sclerosis	0.000321	0.00291	CcSEcCtD
Proguanil—Abdominal pain—Betamethasone—multiple sclerosis	0.000321	0.00291	CcSEcCtD
Proguanil—Abdominal pain—Dexamethasone—multiple sclerosis	0.000321	0.00291	CcSEcCtD
Proguanil—Cough—Methotrexate—multiple sclerosis	0.000316	0.00286	CcSEcCtD
Proguanil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000312	0.00744	CbGpPWpGaD
Proguanil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000312	0.00744	CbGpPWpGaD
Proguanil—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000308	0.00734	CbGpPWpGaD
Proguanil—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000308	0.00734	CbGpPWpGaD
Proguanil—Decreased appetite—Prednisone—multiple sclerosis	0.000308	0.00279	CcSEcCtD
Proguanil—Rash—Prednisolone—multiple sclerosis	0.000307	0.00278	CcSEcCtD
Proguanil—Dermatitis—Prednisolone—multiple sclerosis	0.000307	0.00278	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000306	0.00278	CcSEcCtD
Proguanil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000306	0.00277	CcSEcCtD
Proguanil—Headache—Prednisolone—multiple sclerosis	0.000305	0.00276	CcSEcCtD
Proguanil—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000298	0.00712	CbGpPWpGaD
Proguanil—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000298	0.00712	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—CCL2—multiple sclerosis	0.000296	0.00706	CbGpPWpGaD
Proguanil—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000296	0.00705	CbGpPWpGaD
Proguanil—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000296	0.00705	CbGpPWpGaD
Proguanil—Nervous system disorder—Methotrexate—multiple sclerosis	0.00029	0.00263	CcSEcCtD
Proguanil—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000289	0.00262	CcSEcCtD
Proguanil—Nausea—Prednisolone—multiple sclerosis	0.000289	0.00262	CcSEcCtD
Proguanil—Skin disorder—Methotrexate—multiple sclerosis	0.000287	0.0026	CcSEcCtD
Proguanil—Vomiting—Triamcinolone—multiple sclerosis	0.000285	0.00258	CcSEcCtD
Proguanil—Vomiting—Methylprednisolone—multiple sclerosis	0.000284	0.00257	CcSEcCtD
Proguanil—Rash—Triamcinolone—multiple sclerosis	0.000282	0.00256	CcSEcCtD
Proguanil—Dermatitis—Triamcinolone—multiple sclerosis	0.000282	0.00256	CcSEcCtD
Proguanil—Anorexia—Methotrexate—multiple sclerosis	0.000282	0.00255	CcSEcCtD
Proguanil—Rash—Methylprednisolone—multiple sclerosis	0.000282	0.00255	CcSEcCtD
Proguanil—Dermatitis—Methylprednisolone—multiple sclerosis	0.000281	0.00255	CcSEcCtD
Proguanil—Headache—Triamcinolone—multiple sclerosis	0.00028	0.00254	CcSEcCtD
Proguanil—Headache—Methylprednisolone—multiple sclerosis	0.00028	0.00254	CcSEcCtD
Proguanil—Body temperature increased—Prednisone—multiple sclerosis	0.00028	0.00253	CcSEcCtD
Proguanil—Abdominal pain—Prednisone—multiple sclerosis	0.00028	0.00253	CcSEcCtD
Proguanil—Diarrhoea—Betamethasone—multiple sclerosis	0.000278	0.00252	CcSEcCtD
Proguanil—Diarrhoea—Dexamethasone—multiple sclerosis	0.000278	0.00252	CcSEcCtD
Proguanil—DHFR—Folate Metabolism—ALB—multiple sclerosis	0.000276	0.00657	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000267	0.00637	CbGpPWpGaD
Proguanil—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000267	0.00637	CbGpPWpGaD
Proguanil—Nausea—Triamcinolone—multiple sclerosis	0.000266	0.00241	CcSEcCtD
Proguanil—Nausea—Methylprednisolone—multiple sclerosis	0.000265	0.0024	CcSEcCtD
Proguanil—Vomiting—Dexamethasone—multiple sclerosis	0.000258	0.00234	CcSEcCtD
Proguanil—Vomiting—Betamethasone—multiple sclerosis	0.000258	0.00234	CcSEcCtD
Proguanil—Decreased appetite—Methotrexate—multiple sclerosis	0.000257	0.00233	CcSEcCtD
Proguanil—Rash—Betamethasone—multiple sclerosis	0.000256	0.00232	CcSEcCtD
Proguanil—Rash—Dexamethasone—multiple sclerosis	0.000256	0.00232	CcSEcCtD
Proguanil—Dermatitis—Dexamethasone—multiple sclerosis	0.000256	0.00232	CcSEcCtD
Proguanil—Dermatitis—Betamethasone—multiple sclerosis	0.000256	0.00232	CcSEcCtD
Proguanil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000255	0.00231	CcSEcCtD
Proguanil—Headache—Dexamethasone—multiple sclerosis	0.000255	0.00231	CcSEcCtD
Proguanil—Headache—Betamethasone—multiple sclerosis	0.000255	0.00231	CcSEcCtD
Proguanil—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000253	0.00603	CbGpPWpGaD
Proguanil—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000253	0.00603	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—IFNG—multiple sclerosis	0.000252	0.006	CbGpPWpGaD
Proguanil—Diarrhoea—Prednisone—multiple sclerosis	0.000242	0.00219	CcSEcCtD
Proguanil—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000242	0.00219	CcSEcCtD
Proguanil—Nausea—Betamethasone—multiple sclerosis	0.000241	0.00219	CcSEcCtD
Proguanil—Nausea—Dexamethasone—multiple sclerosis	0.000241	0.00219	CcSEcCtD
Proguanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000241	0.00574	CbGpPWpGaD
Proguanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000241	0.00574	CbGpPWpGaD
Proguanil—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000237	0.00566	CbGpPWpGaD
Proguanil—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000237	0.00566	CbGpPWpGaD
Proguanil—Body temperature increased—Methotrexate—multiple sclerosis	0.000234	0.00212	CcSEcCtD
Proguanil—Abdominal pain—Methotrexate—multiple sclerosis	0.000234	0.00212	CcSEcCtD
Proguanil—Vomiting—Prednisone—multiple sclerosis	0.000225	0.00204	CcSEcCtD
Proguanil—DHFR—Folate Metabolism—IL1B—multiple sclerosis	0.000224	0.00535	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—IL2—multiple sclerosis	0.000224	0.00533	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000223	0.00533	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000223	0.00533	CbGpPWpGaD
Proguanil—Rash—Prednisone—multiple sclerosis	0.000223	0.00202	CcSEcCtD
Proguanil—Dermatitis—Prednisone—multiple sclerosis	0.000223	0.00202	CcSEcCtD
Proguanil—Headache—Prednisone—multiple sclerosis	0.000222	0.00201	CcSEcCtD
Proguanil—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00022	0.00525	CbGpPWpGaD
Proguanil—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00022	0.00525	CbGpPWpGaD
Proguanil—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000216	0.00515	CbGpPWpGaD
Proguanil—Nausea—Prednisone—multiple sclerosis	0.00021	0.0019	CcSEcCtD
Proguanil—Diarrhoea—Methotrexate—multiple sclerosis	0.000202	0.00183	CcSEcCtD
Proguanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000195	0.00465	CbGpPWpGaD
Proguanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000195	0.00465	CbGpPWpGaD
Proguanil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000188	0.00448	CbGpPWpGaD
Proguanil—Vomiting—Methotrexate—multiple sclerosis	0.000188	0.0017	CcSEcCtD
Proguanil—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000187	0.00447	CbGpPWpGaD
Proguanil—Rash—Methotrexate—multiple sclerosis	0.000186	0.00169	CcSEcCtD
Proguanil—Dermatitis—Methotrexate—multiple sclerosis	0.000186	0.00169	CcSEcCtD
Proguanil—Headache—Methotrexate—multiple sclerosis	0.000185	0.00168	CcSEcCtD
Proguanil—Nausea—Methotrexate—multiple sclerosis	0.000176	0.00159	CcSEcCtD
Proguanil—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000172	0.00411	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000172	0.00411	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000172	0.00411	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00017	0.00405	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00017	0.00405	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000168	0.004	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—TNF—multiple sclerosis	0.000163	0.00388	CbGpPWpGaD
Proguanil—DHFR—E2F transcription factor network—MYC—multiple sclerosis	0.000161	0.00385	CbGpPWpGaD
Proguanil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000161	0.00383	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000158	0.00378	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000158	0.00378	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000157	0.00375	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000157	0.00375	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000156	0.00373	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000156	0.00373	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000155	0.0037	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000155	0.0037	CbGpPWpGaD
Proguanil—DHFR—Metabolism—SRM—multiple sclerosis	0.000152	0.00362	CbGpPWpGaD
Proguanil—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000148	0.00354	CbGpPWpGaD
Proguanil—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000146	0.00348	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	0.00014	0.00334	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000134	0.0032	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000134	0.0032	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000132	0.00316	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000132	0.00316	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—IL6—multiple sclerosis	0.000131	0.00313	CbGpPWpGaD
Proguanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000124	0.00296	CbGpPWpGaD
Proguanil—DHFR—G1/S Transition—MYC—multiple sclerosis	0.000117	0.00279	CbGpPWpGaD
Proguanil—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000117	0.00278	CbGpPWpGaD
Proguanil—DHFR—Disease—GPC5—multiple sclerosis	0.000117	0.00278	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYP27B1—multiple sclerosis	0.000107	0.00255	CbGpPWpGaD
Proguanil—DHFR—Metabolism—CYP24A1—multiple sclerosis	0.000107	0.00255	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000104	0.00247	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000104	0.00247	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000102	0.00244	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000102	0.00244	CbGpPWpGaD
Proguanil—DHFR—Mitotic G1-G1/S phases—MYC—multiple sclerosis	9.86e-05	0.00235	CbGpPWpGaD
Proguanil—DHFR—Metabolism—GPC5—multiple sclerosis	9.77e-05	0.00233	CbGpPWpGaD
Proguanil—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.46e-05	0.00226	CbGpPWpGaD
Proguanil—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9e-05	0.00215	CbGpPWpGaD
Proguanil—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	8.61e-05	0.00205	CbGpPWpGaD
Proguanil—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.28e-05	0.00197	CbGpPWpGaD
Proguanil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.21e-05	0.00196	CbGpPWpGaD
Proguanil—DHFR—Metabolism—RRM1—multiple sclerosis	8.1e-05	0.00193	CbGpPWpGaD
Proguanil—DHFR—Disease—RPL5—multiple sclerosis	7.59e-05	0.00181	CbGpPWpGaD
Proguanil—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.3e-05	0.00174	CbGpPWpGaD
Proguanil—DHFR—Disease—SLC11A1—multiple sclerosis	7.27e-05	0.00173	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	7.22e-05	0.00172	CbGpPWpGaD
Proguanil—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.01e-05	0.00167	CbGpPWpGaD
Proguanil—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.71e-05	0.0016	CbGpPWpGaD
Proguanil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.65e-05	0.00159	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.62e-05	0.00158	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.62e-05	0.00158	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.44e-05	0.00154	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.41e-05	0.00153	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.03e-05	0.00144	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.03e-05	0.00144	CbGpPWpGaD
Proguanil—DHFR—Disease—CD28—multiple sclerosis	5.8e-05	0.00138	CbGpPWpGaD
Proguanil—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.69e-05	0.00136	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—SRM—multiple sclerosis	5.42e-05	0.00129	CbGpPWpGaD
Proguanil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.41e-05	0.00129	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.16e-05	0.00123	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.16e-05	0.00123	CbGpPWpGaD
Proguanil—CYP2E1—Biological oxidations—POMC—multiple sclerosis	5.02e-05	0.0012	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.01e-05	0.0012	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5e-05	0.00119	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.91e-05	0.00117	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.67e-05	0.00111	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.67e-05	0.00111	CbGpPWpGaD
Proguanil—DHFR—Metabolism—BCHE—multiple sclerosis	4.65e-05	0.00111	CbGpPWpGaD
Proguanil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.39e-05	0.00105	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—SRM—multiple sclerosis	4.18e-05	0.000998	CbGpPWpGaD
Proguanil—DHFR—Disease—CD86—multiple sclerosis	4.14e-05	0.000987	CbGpPWpGaD
Proguanil—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.88e-05	0.000924	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—SRM—multiple sclerosis	3.85e-05	0.000917	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	3.82e-05	0.000911	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	3.82e-05	0.000911	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—SRM—multiple sclerosis	3.81e-05	0.00091	CbGpPWpGaD
Proguanil—DHFR—Disease—CCR5—multiple sclerosis	3.67e-05	0.000876	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—MYC—multiple sclerosis	3.62e-05	0.000862	CbGpPWpGaD
Proguanil—DHFR—Disease—HLA-A—multiple sclerosis	3.58e-05	0.000853	CbGpPWpGaD
Proguanil—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.57e-05	0.00085	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	3.54e-05	0.000844	CbGpPWpGaD
Proguanil—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.53e-05	0.000843	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.49e-05	0.000833	CbGpPWpGaD
Proguanil—DHFR—Disease—APOE—multiple sclerosis	3.34e-05	0.000797	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—SRM—multiple sclerosis	3.26e-05	0.000777	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MYC—multiple sclerosis	3.23e-05	0.000771	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MAPK1—multiple sclerosis	3.16e-05	0.000754	CbGpPWpGaD
Proguanil—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.02e-05	0.00072	CbGpPWpGaD
Proguanil—DHFR—Disease—CD80—multiple sclerosis	3.02e-05	0.00072	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.95e-05	0.000703	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.95e-05	0.000703	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.89e-05	0.00069	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.88e-05	0.000687	CbGpPWpGaD
Proguanil—DHFR—Metabolism—APOE—multiple sclerosis	2.8e-05	0.000667	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.71e-05	0.000646	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.71e-05	0.000646	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.7e-05	0.000643	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.69e-05	0.000641	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.69e-05	0.000641	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.63e-05	0.000626	CbGpPWpGaD
Proguanil—DHFR—Disease—TYK2—multiple sclerosis	2.55e-05	0.000608	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SRM—multiple sclerosis	2.52e-05	0.0006	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.48e-05	0.000591	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.46e-05	0.000586	CbGpPWpGaD
Proguanil—DHFR—Metabolism—POMC—multiple sclerosis	2.4e-05	0.000573	CbGpPWpGaD
Proguanil—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.33e-05	0.000556	CbGpPWpGaD
Proguanil—DHFR—Disease—CD4—multiple sclerosis	2.31e-05	0.00055	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.3e-05	0.000548	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.3e-05	0.000548	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.24e-05	0.000535	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.23e-05	0.000533	CbGpPWpGaD
Proguanil—DHFR—Metabolism—ALB—multiple sclerosis	2.19e-05	0.000523	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.1e-05	0.000501	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.05e-05	0.00049	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.04e-05	0.000486	CbGpPWpGaD
Proguanil—DHFR—Disease—STAT3—multiple sclerosis	1.79e-05	0.000426	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.77e-05	0.000423	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.77e-05	0.000423	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.74e-05	0.000415	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.73e-05	0.000413	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.66e-05	0.000397	CbGpPWpGaD
Proguanil—DHFR—Disease—MYC—multiple sclerosis	1.66e-05	0.000396	CbGpPWpGaD
Proguanil—DHFR—Disease—TGFB1—multiple sclerosis	1.65e-05	0.000395	CbGpPWpGaD
Proguanil—DHFR—Disease—MAPK1—multiple sclerosis	1.62e-05	0.000387	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.62e-05	0.000387	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.58e-05	0.000377	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.49e-05	0.000355	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.36e-05	0.000324	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.36e-05	0.000324	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.35e-05	0.000322	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.34e-05	0.00032	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.28e-05	0.000306	CbGpPWpGaD
Proguanil—DHFR—Disease—IL6—multiple sclerosis	1.25e-05	0.000297	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.24e-05	0.000295	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.18e-05	0.000281	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.000279	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.16e-05	0.000277	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.06e-05	0.000252	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—APOE—multiple sclerosis	1e-05	0.000239	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.99e-06	0.000238	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—POMC—multiple sclerosis	8.59e-06	0.000205	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ALB—multiple sclerosis	7.83e-06	0.000187	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—APOE—multiple sclerosis	7.72e-06	0.000184	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.71e-06	0.000184	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—APOE—multiple sclerosis	7.1e-06	0.000169	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—APOE—multiple sclerosis	7.04e-06	0.000168	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—POMC—multiple sclerosis	6.63e-06	0.000158	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—POMC—multiple sclerosis	6.1e-06	0.000145	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—POMC—multiple sclerosis	6.04e-06	0.000144	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ALB—multiple sclerosis	6.04e-06	0.000144	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—APOE—multiple sclerosis	6.01e-06	0.000143	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ALB—multiple sclerosis	5.56e-06	0.000133	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ALB—multiple sclerosis	5.51e-06	0.000131	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—POMC—multiple sclerosis	5.16e-06	0.000123	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ALB—multiple sclerosis	4.71e-06	0.000112	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—APOE—multiple sclerosis	4.64e-06	0.000111	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—POMC—multiple sclerosis	3.99e-06	9.51e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALB—multiple sclerosis	3.63e-06	8.67e-05	CbGpPWpGaD
